Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome-Reference-Cited by-同舟云学术

Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome

Published:2016-02-03 Issue:10 Volume:7 Page:11165-11193
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Luo Linlin¹²,McGarvey Peter¹²,Madhavan Subha¹²,Kumar Rakesh³,Gusev Yuriy¹²,Upadhyay Geeta¹²

Affiliation:

1. Innovation Center for Biomedical Informatics (ICBI), Georgetown University Medical Center, Washington, District of Columbia 20007, United States of America

2. Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia 20007, United States of America

3. Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, George Washington University, Washington, District of Columbia 20037, United States of America

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymphocyte antigen 6 family member E suppresses apoptosis and promotes pancreatic cancer growth and migration via Wnt/β-catenin pathway activation;Scientific Reports;2024-08-30

2. Antibody–drug conjugates in gastric cancer: from molecular landscape to clinical strategies;Gastric Cancer;2024-07-04

3. Liver‐specific DICER1 syndrome model mice develop cystic liver tumors with defective primary cilia;The Journal of Pathology;2024-06-26

4. Detection of endometrial cancer in cervico-vaginal fluid and blood plasma: leveraging proteomics and machine learning for biomarker discovery;eBioMedicine;2024-04

5. Identification of basement membrane-related signatures for estimating prognosis, immune infiltration landscape and drug candidates in pancreatic adenocarcinoma;Journal of Cancer;2024